COVID-19

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

A new study found that the COVID-19 death rate in New York has dropped significantly since March.

Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on how growth in the health care and biotech industry can support economic revitalization during and following the COVID-19 pandemic among community and retail pharmacies.

Divergent research findings come as investigators seek to understand whether plasma treatments are effective in patients with COVID-19.

The impact of engineering controls, such as ventilation systems, is greater on limiting the spread of COVID-19 than the impact of the most widely applied measures.

Ardon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.

Patients with mild or no symptoms of COVID-19 may be infectious for just 10 days.

The investigators found that 72% of participants would likely take the vaccine based on data collected from the previously validated COVID-SCORE survey of a sample of more than 13,400 individuals from 19 countries that were hard-hit by the virus.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

They can help patients improve inhalation technique, ensuring better medication adherence.

Pharmacy Times® interviewed John Beckner, RPh, the senior director of strategic initiatives at the NCPA, on the importance of American Pharmacists Month in acknowledging the critical role of pharmacists in supporting the US health care system.

The relationship between the flu and heart disease is of particular concern during the pandemic, as severe COVID-19 outcomes have also been associated with exacerbated cardiovascular conditions.

Pharmacy Times spoke with Maggie Ryman, a member of McKesson’s Critical Care Drug Task Force, about anticipating hospital pharmacy needs during COVID-19 and American Pharmacist Month.

Because restrictions have led to widespread demoralization and frustration, the authors said there has been renewed public interest natural herd immunity approaches.

Gilead Sciences' remdesivir is the first drug to receive FDA approval for treating COVID-19 in the United States.

Thirty-four percent of people in Turkey and 17% of people in the UK report that they are “hesitant” about a COVID-19 vaccine, primarily based on the their beliefs regarding the origin of the virus.

Patients with current or former smoking status may be at an increased risk of severe illness due to COVID-19.

Physicians and scientists tested several oral and nasopharyngeal rinses in a laboratory setting for their ability to inactivate human coronaviruses that are similar in structure to SARS-CoV-2.

According to Amy Kallo, a PharmD student at Midwestern University, working at a pharmacy during the pandemic helped to solidify her understanding of the role of pharmacists as educators in their communities.

Barring a successful vaccine, COVID-19 may experience a yearly outbreak similar to the flu.

An expert panel discussed the changes to their businesses, due to the COVID-19 pandemic, and what they think the future holds for specialty pharmacy.

The trial’s main goal is to compare the health status of participants in the combination treatment group with participants in the remdesivir-only group on day 7.

The US Department of Health & Human Services released guidance at the beginning of the pandemic clarifying guidelines regarding best practices in HIV care.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Lennartz said it’s important that pharmacists are properly reimbursed for the administration of many common immunizations, including the flu vaccine.